Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthew D. Storck is active.

Publication


Featured researches published by Matthew D. Storck.


Scientific Reports | 2016

Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development

Sohinee Bhattacharyya; Mark A. Rainey; Priyanka Arya; Samikshan Dutta; Manju George; Matthew D. Storck; Rodney D. McComb; David Muirhead; Gordon L. Todd; Karen A. Gould; Kaustubh Datta; Janee Gelineau Van Waes; Vimla Band; Hamid Band

Members of the four-member C-terminal EPS15-Homology Domain-containing (EHD) protein family play crucial roles in endocytic recycling of cell surface receptors from endosomes to the plasma membrane. In this study, we show that Ehd1 gene knockout in mice on a predominantly B6 background is embryonic lethal. Ehd1-null embryos die at mid-gestation with a failure to complete key developmental processes including neural tube closure, axial turning and patterning of the neural tube. We found that Ehd1-null embryos display short and stubby cilia on the developing neuroepithelium at embryonic day 9.5 (E9.5). Loss of EHD1 also deregulates the ciliary SHH signaling with Ehd1-null embryos displaying features indicative of increased SHH signaling, including a significant downregulation in the formation of the GLI3 repressor and increase in the ventral neuronal markers specified by SHH. Using Ehd1-null MEFS we found that EHD1 protein co-localizes with the SHH receptor Smoothened in the primary cilia upon ligand stimulation. Under the same conditions, EHD1 was shown to co-traffic with Smoothened into the developing primary cilia and we identify EHD1 as a direct binding partner of Smoothened. Overall, our studies identify the endocytic recycling regulator EHD1 as a novel regulator of the primary cilium-associated trafficking of Smoothened and Hedgehog signaling.


Oncotarget | 2016

A novel CBL-B flox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells

Benjamin Goetz; Wei An; Bhopal Mohapatra; Neha Zutshi; Fany Iseka; Matthew D. Storck; Jane L. Meza; Yuri Sheinin; Vimla Band; Hamid Band

CBL-family ubiquitin ligases are critical negative regulators of tyrosine kinase signaling, with a clear redundancy between CBL and CBL-B evident in the immune cell and hematopoietic stem cell studies. Since CBL and CBL-B are negative regulators of immune cell activation, elimination of their function to boost immune cell activities could be beneficial in tumor immunotherapy. However, mutations of CBL are associated with human leukemias, pointing to tumor suppressor roles of CBL proteins; hence, it is critical to assess the tumor-intrinsic roles of CBL and CBL-B in cancers. This has not been possible since the only available whole-body CBL-B knockout mice exhibit constitutive tumor rejection. We engineered a new CBL-Bflox/flox mouse, combined this with an existing CBLflox/flox mouse to generate CBLflox/flox; CBL-Bflox/flox mice, and tested the tissue-specific concurrent deletion of CBL and CBL-B using the widely-used CD4-Cre transgenic allele to produce a T-cell-specific double knockout. Altered T-cell development, constitutive peripheral T-cell activation, and a lethal multi-organ immune infiltration phenotype largely resembling the previous Lck-Cre driven floxed-CBL deletion on a CBL-B knockout background establish the usefulness of the new model for tissue-specific CBL/CBL-B deletion. Unexpectedly, CD4-Cre-induced deletion in a small fraction of hematopoietic stem cells led to expansion of certain non-T-cell lineages, suggesting caution in the use of CD4-Cre for T-cell-restricted gene deletion. The establishment of a new model of concurrent tissue-selective CBL/CBL-B deletion should allow a clear assessment of the tumor-intrinsic roles of CBL/CBL-B in non-myeloid malignancies and help test the potential for CBL/CBL-B inactivation in immunotherapy of tumors.


Developmental Biology | 2015

The endocytic recycling regulatory protein EHD1 Is required for ocular lens development

Priyanka Arya; Mark A. Rainey; Sohinee Bhattacharyya; Bhopal Mohapatra; Manju George; Murali R. Kuracha; Matthew D. Storck; Vimla Band; Venkatesh Govindarajan; Hamid Band

The C-terminal Eps15 homology domain-containing (EHD) proteins play a key role in endocytic recycling, a fundamental cellular process that ensures the return of endocytosed membrane components and receptors back to the cell surface. To define the in vivo biological functions of EHD1, we have generated Ehd1 knockout mice and previously reported a requirement of EHD1 for spermatogenesis. Here, we show that approximately 56% of the Ehd1-null mice displayed gross ocular abnormalities, including anophthalmia, aphakia, microphthalmia and congenital cataracts. Histological characterization of ocular abnormalities showed pleiotropic defects that include a smaller or absent lens, persistence of lens stalk and hyaloid vasculature, and deformed optic cups. To test whether these profound ocular defects resulted from the loss of EHD1 in the lens or in non-lenticular tissues, we deleted the Ehd1 gene selectively in the presumptive lens ectoderm using Le-Cre. Conditional Ehd1 deletion in the lens resulted in developmental defects that included thin epithelial layers, small lenses and absence of corneal endothelium. Ehd1 deletion in the lens also resulted in reduced lens epithelial proliferation, survival and expression of junctional proteins E-cadherin and ZO-1. Finally, Le-Cre-mediated deletion of Ehd1 in the lens led to defects in corneal endothelial differentiation. Taken together, these data reveal a unique role for EHD1 in early lens development and suggest a previously unknown link between the endocytic recycling pathway and regulation of key developmental processes including proliferation, differentiation and morphogenesis.


Oncotarget | 2016

VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease

Wei An; Bhopal Mohapatra; Neha Zutshi; Timothy Alan Bielecki; Benjamin T. Goez; Haitao Luan; Fany Iseka; Insha Mushtaq; Matthew D. Storck; Vimla Band; Hamid Band

CBL and CBL-B ubiquitin ligases play key roles in hematopoietic stem cell homeostasis and their aberrations are linked to leukemogenesis. Mutations of CBL, often genetically-inherited, are particularly common in Juvenile Myelomonocytic Leukemia (JMML), a disease that manifests early in children. JMML is fatal unless corrected by bone marrow transplant, which is effective in only half of the recipients, stressing the need for animal models that recapitulate the key clinical features of this disease. However, mouse models established so far only develop hematological malignancy in adult animals. Here, using VAV1-Cre-induced conditional CBL/CBL-B double knockout (DKO) in mice, we established an animal model that exhibits a neonatal myeloproliferative disease (MPD). VAV1-Cre induced DKO mice developed a strong hematological phenotype at postnatal day 10, including severe leukocytosis and hepatomegaly, bone marrow cell hypersensitivity to cytokines including GM-CSF, and rapidly-progressive disease and invariable lethality. Interestingly, leukemic stem cells were most highly enriched in neonatal liver rather than bone marrow, which, along with the spleen and thymus, were hypo-cellular. Nonetheless, transplantation assays showed that both DKO bone marrow and liver cells can initiate leukemic disease in the recipient mice with seeding of both spleen and bone marrow. Together, our results support the usefulness of the new hematopoietic-specific CBL/CBL-B double KO animal model to study JMML-related pathogenesis and to further understand the function of CBL family proteins in regulating fetal and neonatal hematopoiesis. To our knowledge, this is the first mouse model that exhibits neonatal MPD in infancy, by day 10 of postnatal life.


Cellular Signalling | 2016

CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface.

Luke R. Cypher; Timothy Alan Bielecki; Lu Huang; Wei An; Fany Iseka; Eric Tom; Matthew D. Storck; Adam D. Hoppe; Vimla Band; Hamid Band

Colony stimulating factor-1 receptor (CSF-1R), a receptor tyrosine kinase (RTK), is the master regulator of macrophage biology. CSF-1 can bind CSF-1R resulting in receptor activation and signalling essential for macrophage functions such as proliferation, differentiation, survival, polarization, phagocytosis, cytokine secretion, and motility. CSF-1R activation can only occur after the receptor is presented on the macrophage cell surface. This process is reliant upon the underlying macrophage receptor trafficking machinery. However, the mechanistic details governing this process are incompletely understood. C-terminal Eps15 Homology Domain-containing (EHD) proteins have recently emerged as key regulators of receptor trafficking but have not yet been studied in the context of macrophage CSF-1R signalling. In this manuscript, we utilize primary bone-marrow derived macrophages (BMDMs) to reveal a novel function of EHD1 as a regulator of CSF-1R abundance on the cell surface. We report that EHD1-knockout (EHD1-KO) macrophages cell surface and total CSF-1R levels are significantly decreased. The decline in CSF-1R levels corresponds with reduced downstream macrophage functions such as cell proliferation, migration, and spreading. In EHD1-KO macrophages, transport of newly synthesized CSF-1R to the macrophage cell surface was reduced and was associated with the shunting of the receptor to the lysosome, which resulted in receptor degradation. These findings reveal a novel and functionally important role for EHD1 in governing CSF-1R signalling via regulation of anterograde transport of CSF-1R to the macrophage cell surface.


The FASEB Journal | 2017

EHD4 is a novel regulator of urinary water homeostasis

Shamma S. Rahman; Alexandra E. J. Moffitt; Andrew J. Trease; Kirk W. Foster; Matthew D. Storck; Hamid Band; Erika I. Boesen

The Eps15‐homology domain–containing (EHD) protein family comprises 4 members that regulate endocytic recycling. Although the kidney expresses all 4 EHD proteins, their physiologic roles are largely unknown. This study focused on EHD4, which we found to be expressed differentially across nephron segments with the highest expression in the inner medullary collecting duct. Under baseline conditions, Ehd4−/− [EHD4‐knockout (KO)] mice on a C57Bl/6 background excreted a higher volume of more dilute urine than control C57Bl/6 wild‐type (WT) mice while maintaining a similar plasma osmolality. Urine excretion after an acute intraperitoneal water load was significantly increased in EHD4‐KO mice compared to WT mice, and although EHD4‐KO mice concentrated their urine during 24‐h water restriction, urinary osmolality remained significantly lower than in WT mice, suggesting that EHD4 plays a role in renal water handling. Total aquaporin 2 (AQP2) and phospho‐S256‐AQP2 (pAQP2) protein expression in the inner medulla was similar in the two groups in baseline conditions. However, localization of both AQP2 and pAQP2 in the renal inner medullary principal cells appeared more dispersed, and the intensity of apical membrane staining for AQP2 was reduced significantly (by ~20%) in EHD4‐KO mice compared to WT mice in baseline conditions, suggesting an important role of EHD4 in trafficking of AQP2. Together, these data indicate that EHD4 play important roles in the regulation of water homeostasis.—Rahman, S. S., Moffitt, A. E. J., Trease, A. J., Foster, K. W., Storck, M. D., Band, H., Boesen, E.I. EHD4 is a novel regulator of urinary water homeostasis. FASEB J. 31, 5217–5233 (2017). www.fasebj.org


Oncotarget | 2015

Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy

Wei An; Scott Nadeau; Bhopal Mohapatra; Dan Feng; Neha Zutshi; Matthew D. Storck; Priyanka Arya; James E. Talmadge; Jane L. Meza; Vimla Band; Hamid Band


Cancer Research | 2018

Abstract 92: CHIP/STUB1 ubiquitin ligase targets MZF1 and loss of its expression in breast cancer unleashes a MZF1-cathepsin pro-oncogenic program

Bhopal Mohapatra; Haitao Luan; Timothy A. Bielecki; Insha Mushtaq; Sameer Mirza; Tameka A. Bailey; Robert J. Clubb; Wei An; Dena Ahmed; Rokaya El Ansari; Matthew D. Storck; Chittibabu Guda; Yuri Sheinin; Jane L. Meza; Srikumar M. Raja; Emad A. Rakha; Vimla Band; Hamid Band


Cancer Research | 2018

Abstract 2517: The role of endocytic traffic regulator EHD1 in EGFR traffic and breast cancer

Insha Mushtaq; Eric Tom; Priyanka Arya; Timothy A. Bielecki; Bhopal Mohapatra; Sameer Mirza; Matthew D. Storck; Dena Ahmad; Rokaya El Ansari; Emad A. Rakha; Vimla Band; Hamid Band


Journal of Cell Science | 2017

An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance

Bhopal Mohapatra; Neha Zutshi; Wei An; Benjamin Goetz; Priyanka Arya; Timothy Alan Bielecki; Insha Mustaq; Matthew D. Storck; Jane L. Meza; Vimla Band; Hamid Band

Collaboration


Dive into the Matthew D. Storck's collaboration.

Top Co-Authors

Avatar

Hamid Band

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Vimla Band

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Bhopal Mohapatra

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Wei An

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Neha Zutshi

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Priyanka Arya

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Timothy Alan Bielecki

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Fany Iseka

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Jane L. Meza

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Benjamin Goetz

University of Nebraska Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge